India's first Ayurvedic anti-diabetic drug, BGR-34, launched by CSIR
BGR-34 is designed for type 2 Diabetes mellitus, has been scientifically validated for its efficacy and safety.
Council for Scientific and Industrial Research (CSIR) on 3 February 2016 launched the BGR-34, the country's first anti-diabetic ayurvedic drug for Diabetes. BGR is acronym for blood glucose regulator.
The ayurvedic drug BGR-34 was launched at Kozhikode, Kerala by CSIR's Senior Principal Scientist Dr AKS Rawat as part of the Global Ayurveda Festival in the city.
BGR-34 is designed for type 2 Diabetes mellitus, has been scientifically validated for its efficacy and safety. Priced at 5 rupees per tablet, the medicine is now available at all major chemist counters of Kerala.
The drug works by controlling blood sugar level (anti-hyperglycaemic property) and limiting the harmful effects of other drugs and is not toxic in nature nor carries any side-effects.
The drug was developed by CSIR in collaboration with National Botanical Research Institute and Central Institute for Medicinal and Aromatic Plant. It was developed as diabetes has become a major threat in the health sector and about 6 crore of adult Indian population has been found to be diabetic and there is no effective solution for the disease yet.
Now get latest Current Affairs on mobile, Download # 1 Current Affairs App